Publications by authors named "Neil Swanson"

Claim this Profile
U
UK multisociety consensus statement on the emergency management and resuscitation of patients with left-sided Impella support.
Waqas Akhtar, Christopher T Bowles, Pierluigi Costanzo, Charles D Deakin, Pauline Elliot, Neil Swanson

Heart· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British societies guideline on the management of emergencies in patients on extracorporeal membrane oxygenation.
Waqas Akhtar, Neil Brain, Clara Hernandez Caballero, Luigi Camporota, Charles D Deakin, Neil Swanson

Intensive Care Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British societies guideline on the management of emergencies in implantable left ventricular assist device recipients in transplant centres.
Waqas Akhtar, Veronica Rial Baston, Marius Berman, Sai Bhagra, Colin Chue, Neil Swanson

Intensive Care Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma.
Guilherme Rabinowits, Michael R Migden, Todd E Schlesinger, Robert L Ferris, Morganna Freeman, Neil Swanson

JID Innov· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Aspirin Desensitization is Safe and Feasible in Patients With Stable and Unstable Coronary Artery Disease: A Single-Center Experience.
Matthew Jackson, Sarah Callaghan, John Stapleton, Sarah Bolton, David Austin, Neil Swanson

J Cardiovasc Pharmacol Ther· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after culprit-only percutaneous coronary intervention for multivessel disease during ST-segment elevation myocardial infarction: a comparison of registry and clinical trial outcomes.
Matthew W P Jackson, David Austin, Neil Swanson, Paul D Williams, Douglas F Muir

Coron Artery Dis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imiquimod 2.5% and 3.75% Cream for the Treatment of Photodamage: A Meta-analysis of Efficacy and Tolerability in 969 Randomized Patients.
James Del Rosso, Neil Swanson, Brian Berman, George M Martin, Tina Lin

J Clin Aesthet Dermatol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or Chest.
C William Hanke, Brian Berman, Neil Swanson, David M Pariser, Jonathan S Weiss

J Drugs Dermatol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm Meeting.
Seemal R Desai, Ilona J Frieden, Joel M Gelfand, Whitney High, Arthur Kavanaugh, Neil Swanson

J Clin Aesthet Dermatol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total- and methyl-mercury concentrations and methylation rates across the freshwater to hypersaline continuum of the Great Salt Lake, Utah, USA.
William P Johnson, Neil Swanson, Brooks Black, Abigail Rudd, Greg Carling

Sci Total Environ· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2014 MauiDerm Meeting.
Neal Bhatia, Andrew Blauvelt, Marc Brown, Whitney High, Craig T Leonardi, Neil A Swanson

J Clin Aesthet Dermatol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results.
Brian Berman, Gary Goldenberg, C William Hanke, Stephen K Tyring, Wm Philip Werschler, Neil Swanson

J Drugs Dermatol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results.
Brian Berman, Gary Goldenberg, C William Hanke, Stephen K Tyring, Wm Philip Werschler, Neil Swanson

J Drugs Dermatol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Neil Swanson, Christina Cognata Smith, Mandeep Kaur, Gary Goldenberg

J Drugs Dermatol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies.
Neil Swanson, Christina Cognata Smith, Mandeep Kaur, Gary Goldenberg

J Drugs Dermatol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.
Andrew Blauvelt, Marc Brown, Kenneth B Gordon, Arthur Kavanaugh, Craig T Leonardi, Neil A Swanson

J Clin Aesthet Dermatol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical findings using ingenol mebutate gel to treat actinic keratoses.
George Martin, Neil Swanson

J Am Acad Dermatol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tri-modal confocal mosaics detect residual invasive squamous cell carcinoma in Mohs surgical excisions.
Dan Gareau, Anna Bar, Nicholas Snaveley, Ken Lee, Nathaniel Chen, Neil Swanson

J Biomed Opt· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoepithelioma-like carcinoma in a patient with mycosis fungoides.
Alexander R Jack, Nicholas R Snavely, Kevin P White, Neil A Swanson

J Drugs Dermatol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ingenol mebutate gel for actinic keratosis.
Mark Lebwohl, Neil Swanson, Lawrence L Anderson, Anita Melgaard, Zhenyi Xu

N Engl J Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream.
C William Hanke, Neil Swanson, Suzanne Bruce, Brian Berman, James Kulp

J Drugs Dermatol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles.
Neil Swanson, William Abramovits, Brian Berman, James Kulp, Darrell S Rigel

J Am Acad Dermatol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Door to balloon times: streamlining admission for primary percutaneous coronary intervention.
Neil Swanson, Christopher Nunn, Steve Holmes, Gerry Devlin

N Z Med J· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term mortality after primary percutaneous coronary intervention for high-risk myocardial infarction.
Neil M G Swanson, Gerry P Devlin, Gaelle Dutu, Steve Holmes, Christopher M Nunn

Heart Lung Circ· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.
Fredric Brandt, Neil Swanson, Leslie Baumann, Barbara Huber

Dermatol Surg· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis